We have observed that the highly overexpressed ASCL1 and NEUROD1 activators target more than one third of the total number of genes expressed in SCLC (8,131 and 7,329, respectively; Table 1, Fig 1B and C). The gene discussed is NEUROD1; the disease is small cell lung carcinoma.